Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Advertising and Sponsorship
    • Profile & Readership
    • Contact Us
    • Latest News
    • Privacy & Cookies Policies
    • Terms of Use
    • Advertising Terms
    • Issue 81
    • Issue 80
    • Issue 79
    • Issue 78
    • Issue 77
    • Issue 76
    • Issue 75
    • Issue 74
    • Issue 73
    • Issue 72
    • Issue 71
    • Issue 70
    • View All
    • About the Awards
    • Awards Timetable
    • Awards Winners
    • Submit Nominations
    • Testimonials
    • Media Room
    • FAQ
    • Asset Management Awards
    • Brand of the Year Awards
    • Business Awards
    • Cash Management Banking Awards
    • Banking Technology Awards
    • CEO Awards
    • Customer Service Awards
    • CSR Awards
    • Deal of the Year Awards
    • Corporate Governance Awards
    • Corporate Banking Awards
    • Digital Transformation Awards
    • Fintech Awards
    • Education & Training Awards
    • ESG & Sustainability Awards
    • ESG Awards
    • Forex Banking Awards
    • Innovation Awards
    • Insurance & Takaful Awards
    • Investment Banking Awards
    • Investor Relations Awards
    • Leadership Awards
    • Islamic Banking Awards
    • Real Estate Awards
    • Project Finance Awards
    • Process & Product Awards
    • Telecommunication Awards
    • HR & Recruitment Awards
    • Trade Finance Awards
    • The Next 100 Global Awards
    • Wealth Management Awards
    • Travel Awards
    • Years of Excellence Awards
    • Publishing Principles
    • Ownership & Funding
    • Corrections Policy
    • Editorial Code of Ethics
    • Diversity & Inclusion Policy
    • Fact Checking Policy
    Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

    A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

    Copyright © 2010-2026 - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    1. Home
    2. >Finance
    3. >Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill
    Finance

    Amazon Pharmacy Starts Offering Novo Nordisk's Wegovy Weight-Loss Pill

    Published by Global Banking & Finance Review®

    Posted on January 9, 2026

    2 min read

    Last updated: January 20, 2026

    Add as preferred source on Google
    Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:insurancehealthcaree-commerce

    Quick Summary

    Amazon Pharmacy now offers Novo Nordisk's Wegovy weight-loss pill, available via insurance and cash-pay. The pill provides an alternative to injectables.

    Amazon Pharmacy Launches Novo Nordisk's Wegovy Weight-Loss Pill

    Amazon Pharmacy and Wegovy: A New Weight-Loss Option

    Jan 9 (Reuters) - Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy weight-loss pill through insurance plans as well as through a cash-pay option.

    Pricing and Availability

    Eligible customers with commercial insurance may pay $25 for a one-month supply, while those without insurance can pay cash, starting at $149 per month, the company said.

    Partnerships with Telehealth Providers

    In the next few weeks, the Wegovy pill will also be available through Amazon Pharmacy kiosks, it said.

    Market Impact and Consumer Reach

    The U.S. Food and Drug Administration approved Novo's weight-loss pill in December, which has the same active ingredient as its blockbuster injectable weight-loss and diabetes treatments, marketed under the brand names Wegovy and Ozempic.

    The Danish drugmaker earlier this month said it is offering doses of 1.5 milligrams and 4 mg of the once-daily Wegovy pill at $149 per month for self-paying U.S. patients.

    The Wegovy pill could attract new consumers as Novo looks to revive its fortunes after profit warnings and sliding shares last year. The treatment offers more flexibility and an alternative for those who dislike needles used in injectable medication.

    The pill would be available through U.S. pharmacies CVS and Costco, as well as through telehealth providers including Ro, LifeMD, WeightWatchers, GoodRx and its own NovoCare Pharmacy, the drugmaker had said.

    Amazon Pharmacy is also collaborating with telehealth firms including WeightWatchers, Wheel and 9amHealth to help expand access to the weight-loss treatment, it said on Friday.

    The success of Novo's pill will be tied to attracting cash-paying consumers who cannot get insurance coverage, a stark shift from the dominant business model where drug pricing is managed through health insurance plans.

    (Reporting by Sneha S K in Bengaluru; Editing by Krishna Chandra Eluri and Sahal Muhammed)

    Table of Contents

    • Amazon Pharmacy and Wegovy: A New Weight-Loss Option
    • Pricing and Availability
    • Partnerships with Telehealth Providers
    • Market Impact and Consumer Reach

    Key Takeaways

    • •Amazon Pharmacy offers Wegovy through insurance and cash-pay.
    • •Wegovy is FDA approved and offers flexibility over injectables.
    • •Novo Nordisk partners with telehealth providers for distribution.
    • •The pill targets cash-paying consumers without insurance.
    • •Wegovy aims to boost Novo's market presence after past setbacks.

    Frequently Asked Questions about Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill

    1What is Wegovy?

    Wegovy is a prescription medication developed by Novo Nordisk used for weight management in adults with obesity or overweight conditions. It works by mimicking a hormone that regulates appetite.

    2What is Amazon Pharmacy?

    Amazon Pharmacy is a service provided by Amazon that allows customers to order prescription medications online, often with options for insurance coverage or cash payment.

    3What is a cash-pay option?

    A cash-pay option allows customers to purchase medications without using insurance, paying the full price directly at the time of purchase.

    4What is the role of insurance in pharmaceuticals?

    Insurance in pharmaceuticals helps cover the cost of medications for patients, reducing out-of-pocket expenses and making prescriptions more affordable.

    More from Finance

    Explore more articles in the Finance category

    Image for UK inflation holds at 3.0% in February
    UK Inflation Holds at 3.0% in February
    Image for Fastweb + Vodafone terminates agreement with INWIT
    Fastweb + Vodafone Terminates Agreement With Inwit
    Image for Asia looks to COVID-era playbook to tackle fuel crisis
    Asia Looks to COVID-era Playbook to Tackle Fuel Crisis
    Image for Analysis-Western powers were unable to secure shipping in the Red Sea. Hormuz will be harder
    Analysis-Western Powers Were Unable to Secure Shipping in the Red Sea. Hormuz Will Be Harder
    Image for Air Liquide executive: will allocate helium volume from other places in the world
    Air Liquide Executive: Will Allocate Helium Volume From Other Places in the World
    Image for Blaze at Russia's Baltic Sea port of Ust-Luga after major Ukrainian drone attack
    Blaze at Russia's Baltic Sea Port of Ust-Luga After Major Ukrainian Drone Attack
    Image for Morning Bid: Deal, or no deal?
    Morning Bid: Deal, or No Deal?
    Image for Labubu maker Pop Mart meets 2025 revenue expectations
    Labubu Maker Pop Mart Meets 2025 Revenue Expectations
    Image for Israel strikes Tehran as Trump says US negotiating to end war
    Israel Strikes Tehran as Trump Says US Negotiating to End War
    Image for South Korea, Germany exposed to rare earths shortage, Australia's Arafura says
    South Korea, Germany Exposed to Rare Earths Shortage, Australia's Arafura Says
    Image for Currency markets drift as traders sceptical of US efforts to end Iran war
    Currency Markets Drift as Traders Sceptical of US Efforts to End Iran War
    Image for Stocks bounce and oil retreats on Mideast ceasefire reports
    Stocks Bounce and Oil Retreats on Mideast Ceasefire Reports
    View All Finance Posts
    Previous Finance PostItaly to Spend 1 Billion Euros to Cut Energy Prices, PM Meloni Says
    Next Finance PostItaly's PM Open to Selling Government Stake in Monte Paschi but Sees No Rush